Clinical Trials in Houston

Showing 2921-2940 of 15,366 trials

RECRUITING< 1 mile

Multi-center MRD Registry for Inflammatory Breast Cancer

NCT06966050

To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.

Breast Cancer

M.D. Anderson Cancer Center200 participantsStarted May 2025

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)

NCT05899816

The primary objectives of this study are to: * estimate vaccine response in rocatinlimab group vs placebo group, assessed using antibody anti-tetanus response at Week 24 * estimate vaccine response in rocatinlimab group vs placebo group, assessed using antibody anti-meningococcal response at Week 24

Atopic DermatitisModerate-to-severe Atopic Dermatitis

Amgen221 participantsStarted Jun 2023

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • Scottsdale, Arizona, United States +82 more locations

Multi-center MRD Registry for Inflammatory Breast Cancer

A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)

Find Trials by Condition in Houston

Care Coordination System for People With Dementia

A Study of CDPATH™ to Help Manage and Treat Crohn's Disease

A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Prevention of Serious Adverse Events Following Angiography

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC)

A Study of LY3405105 in Participants With Advanced Cancer

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas

Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum

A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study